Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Allarity Therapeutics, Inc. (ALLR) had Normalized Income after Taxes of $-2.75M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.03M |
|
$-2.75M |
|
-- |
|
$0.03M |
|
$2.71M |
|
$-2.69M |
|
$-0.06M |
|
$-2.75M |
|
$-2.75M |
|
$-2.75M |
|
$-2.75M |
|
$-2.75M |
|
|
Normalized Income after Taxes |
$-2.75M |
$-2.69M |
|
$-2.71M |
|
15.97M |
|
15.97M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$34.50M |
|
$0.42M |
|
$0.42M |
|
$34.92M |
|
$28.00M |
|
-- |
|
-- |
|
$28.00M |
|
$6.92M |
|
$6.92M |
|
$6.92M |
|
15.82M |
|
| Cash Flow Statement Financials | |
$-4.49M |
|
$-0.06M |
|
$19.74M |
|
$14.69M |
|
$29.81M |
|
$15.12M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
-- |
|
3.11 |
|
100.00% |
|
-10752.00% |
|
-10752.00% |
|
-- |
|
-11000.00% |
|
-11000.00% |
|
$-4.56M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
3895.20 |
|
-39.74% |
|
-39.74% |
|
-7.87% |
|
-39.74% |
|
$0.44 |
|
$-0.29 |
|
$-0.28 |
|